-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.P1.76 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, apheresis, antibodies, Biological, Diseases, cellular interactions, Non-Biological, Therapies, Mechanisms, Pediatric, cell expansion, Technology and Procedures, chemotherapy, checkpoint inhibitor, Study Population, Clinically relevant, Lymphoid Malignancies, immunotherapy, Myeloid Malignancies, immune mechanism, NK cells, flow cytometry, inflammation, molecular testing, transplantation, molecular interactions, pathogenesis, signal transduction
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)

Shahinaz M Gadalla, MD, PhD1*, Weiyin Zhou, MS1*, Tao Wang, PhD2,3*, Yoshitaka Zaimoku, MD4*, Shinji Nakao, MD5, Laurie Burdette, PhD1*, Amanda Willis, BS6*, Medhat Askar, MD, PhD6*, Michael Haagenson, MS7*, Meredith Yeager, PhD1*, Youjin Wang1*, Stephen R. Spellman7*, Stephen J Chanock, MD1*, Stephanie J. Lee, MD, PhD2,8* and Sharon A Savage, MD1

1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
2Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
3Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
4Department of Hematology, Kanazawa University, Kanazawa, Japan
5Kanazawa University Grad. School of Med. Science, Kanazawa, Japan
6Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, TX
7Center for International Blood and Marrow Transplant Research, Minneapolis, MN
8Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Marie Robin, MD, PhD1, Raphael Porcher, PhD2*, Laetitia Taurines3*, Bastien Oriano2*, Regis Peffault De Latour, MD, PhD4*, Flore Sicre De Fontbrune, MD5*, David Michonneau, MD, PhD4*, Nathalie Dhedin, MD6*, Christine Chomienne, MD, PhD3, Gérard Socié, MD, PhD5 and Marie-Hélène Schlageter, PharmD3*

1Hematology / Transplantation, Hopital Saint-Louis, Paris Cedex 10, France
2Centre d'épidémiologie clinique, Hôpital Hôtel-Dieu AP-HP, Paris, France
3Unité de Biologie Cellulaire, Hôpital Saint-Louis AP-HP, PARIS Cedex 10, France
4Hematology / Transplantation, Hôpital Saint-Louis AP-HP, PARIS Cedex 10, France
5Hopital Saint-Louis, Paris, France
6Department of Hematology, University Hospital Saint-Louis, PARIS, France

Bita Sahaf, PhD1*, Dmitry Tebaykin, PhD1*, Melissa Hopper, MS2*, Patricia Cheung, PhD2*, Fabiola Bittencourt, PhD2*, Corey S. Cutler, MD, MPH3*, Mukta Arora, MD4, Edmund K. Waller, MD 5, Madan Jagasia, MD, MBBS, MS6, Iskra Pusic, MD7, Mary E. Flowers, MD8, Aaron C. Logan, MD, PhD, MPhil9, Samantha Jaglowski, MD, MPH10, Jason Lih, PhD2*, Isabelle Solman, MS2*, Indu D. Lal, MD2*, Lori Styles, MD2*, John S. Hill, PhD2*, Danelle F. James, MD, MAS11*, Sean Bendall, PhD1*, David B. Miklos, MD, PhD12* and Jason Dubovsky, PhD2*

1Stanford University School of Medicine, Stanford, CA
2Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
3Dana-Farber Cancer Institute, Boston, MA
4University of Minnesota, Minneapolis, MN
5Winship Cancer Institute of Emory University, Atlanta, GA
6Vanderbilt-Ingram Cancer Center, Nashville, TN
7Washington University School of Medicine, St. Louis, MO
8Fred Hutchinson Cancer Research Center, Seattle, WA
9University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francicso, CA
10The Ohio State Univ. Comprehensive Cancer Center, Columbus, OH
11Pharmacyclics LLC, Sunnyvale, CA
12Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University Medical Center, Stanford, CA

Zhenkun Wang, PhD1*, Limin Li, MD2*, Hongjuan Yu, PhD3*, Fenglin Cao, MD, PhD3*, Yang Xiao, MD4, Zenghui Liu, MD5*, Ce Shi, MD, PhD3*, Zhiyu Liu, MD2*, Weijia Feng, MD2*, Xiaolong Liu2* and Jin Zhou6*

1First Hospital of Harbin, Med. Univ., Harbin, China
2First Hospital of Harbin, Med. Univ., harbin, China
3First Hospital of Harbin, Med. Univ., Harbin, CHN
4General Military Regional Hosp. of Guangdong, Guangzhou, CHN
5General Military Regional Hosp. of Guangdong, guangzhou, China
6Department of Hemotology, The First Hospital, Harbin Medical University, Harbin, China

Sarah A Wall, MD1, Qiuhong Zhao, MS2*, Parvathi Ranganathan, PhD1, Patrick Elder1*, Basem M. William, MD2*, Marcin Puto, PharmD1*, Julianna Roddy, PharmD1*, Rebecca B. Klisovic, MD3*, William Blum, MD3, Don M Benson Jr., MD, PhD1, Samantha Jaglowski, MD, MPH2, Alice S. Mims, MD, MSCR2, Jonathan E Brammer, MD2, Yvonne A Efebera, MD1, Craig C Hofmeister, MD2, Leslie Andritsos, MD2, Sam Penza, MD2, Alison R. Walker, MD4, Steven M. Devine, MD2, Spero R Cataland, MD2 and Sumithira Vasu, MD, MBBS2

1The Ohio State University, Columbus, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
3Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
4Division of Hematology, Department of Internal Medicine, The Ohio State Univ. Medical Ctr., Columbus, OH

Ifigeneia Tzannou, MD1*, Anastasia Papadopoulou, PhD1*, Ayumi Watanabe1*, Manik Kuvalekar1*, Adrian P. Gee, PhD1, Swati Naik, MBBS1*, Caridad A. Martinez, MD1*, Kathryn Leung, MD1*, Ghadir Sasa, MD1*, Premal Lulla, MBBS2, Robert A. Krance, MD1, George Carrum, MD1, Carlos A. Ramos, MD1, Juan F. Vera, MD1*, Bambi J. Grilley, RPh1*, Malcolm K. Brenner, MD, PhD1*, Cliona M. Rooney, PhD1*, Helen E. Heslop, MD, DSc1, Ann M. Leen, PhD1 and Bilal Omer, MD1*

1Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX
2Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

Jacopo Mariotti1*, Angela Granata, MD2*, Raynier Devillier2*, Stefania Bramanti, MD3*, Barbara Sarina, MD4*, Sabine Furst, MD2*, Catherine Faucher, MD2*, Samia Harbi, MD2*, Lucio Morabito5*, Christian Chabannon, MD, PhD6, Carmelo Carlo-Stella, MD7, Reda Bouabdallah, MD8*, Armando Santoro, MD3*, Didier Blaise9 and Luca Castagna, MD10*

1Haematology, Humanitas Cancer Center, Rozzano (milan), Italy
2Institut Paoli Calmettes, Marseille, France
3Humanitas Clinical and Research Center, Rozzano, Italy
4Haematology, Istituto Clinico Humanitas, Rozzano, Italy
5Cancer Center, Humanitas Research Hospital and Center for Accelerating Leukemia Research (CALR), Humanitas University, Milan, Italy
6Institut Paoli Calmettes CLCC Provence-Alpes-Cote d'Azur, Marseille, France
7Department of Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Italy
8Institut Paoli Calmettes, Marseille, FRA
9Institut Paoli Calmettes, Department of Hematology, Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France
10Hematology Department, Istituto Clinico Humanitas, Milano, Italy

Margaret L. MacMillan, MD1, Shernan G. Holtan, MD2, Armin Rashidi, MD, PhD3, Todd E. DeFor, MS4*, Bruce Blazar, MD5 and Daniel J. Weisdorf, MD6

1Blood and Marrow Transplant Program, University Of Minnesota, Minneapolis, MN
2Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
3Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
4Adult and Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN
5Department of Pediatrics, University of Minnesota, Minneapolis, MN
6Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, Minneapolis, MN

Giljun Park, PhD1*, Daehong Kim1,2*, Sofie Lundgren1,2*, Rajiv K Khajuria2*, Ana M Hurtado3*, Cecilia Muñoz-Calleja, Dra4,5*, Laura Cardeñoso5,6*, Samuli Eldfors7*, Pekka Ellonen8*, Sari Hannula7*, Oscar Brück1,2*, Anna Kreutzman, PhD1,2*, Andres Jerez9*, Maija Itälä-Remes, MD, PhD10,11*, Mikko A Keränen, MD, PhD2* and Satu Mustjoki, MD, PhD1,2

1Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
2Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland
3Hematology and Medical Oncology Department, Hospital Morales Meseguer, Universidad de Murcia, MURCIA, Spain
4Department of Immunology, Hospital Universitario de La Princesa, Madrid, Spain
5Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain
6Department of Microbiology, Hospital Universitario de La Princesa, Madrid, Spain
7Institute of Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
8Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
9Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, MURCIA, Spain
10Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
11Turku University Hospital, Stem cell transplantation unit, Turku, Finland

Jan Styczynski, MD PhD1, Gloria Tridello2*, Nina Knelange3*, Per T. Ljungman, MD, PhD4, Lidia Anna Gil, MD, PhD5, Malgorzata Mikulska6*, Gerard Socie7*, Patrice Chevallier, MD, PhD8*, Didier Blaise9, Ibrahim Yakoub-Agha10, Noel Milpied, MD11, Jan J. Cornelissen, MD, PhD12, Johan Maertens, MD, PhD13*, Eefke Petersen, MD14, Veronique Leblond15, Joan Hendrik Veelken, MD, PhD16, Michel Schaap, MD, PhD17*, Jakob R. Passweg, MD, MS18, Mauricette Michallet, MD, Prof.19, Nathalie Fegueux20*, Eric Deconinck, MD, PhD21, Nigel H. Russell, MD22, Grzegorz Basak, MD, PhD23*, Silvia Montoto, MD24, Nicolaus Kröger25* and Simone Cesaro, MD26*

1Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
2Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
3EBMT Data Office, Leiden, Netherlands
4Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
5Department of Hematology, Poznan University of Medical Sciences, Poznan, Poland
6Division of Infectious Diseases, University of Genova, Ospedale Policlinco San Martino, Genova, Italy
7Haematology, Hopital Saint-Louis, Paris, France
8Department of Hematology, Nantes University Hospital, Nantes, France
9Institut Paoli Calmettes, Department of Hematology, Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France
10CHU de Lille, LIRIC, INSERM U995, Université de Lille2, Lille, France
11Service d’Hematologie Clinique et Therapie Cellulaire, CHU Haut-Lévêque, Bordeaux, France
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
13Department of Hematology, University Hospital Gasthuisberg Leuven, Leuven, Belgium
14University Medical Center, Utrecht, Netherlands
15Department of Clinical Hematology, AP-HP Hôpital Pitié-Salpêtrière, Paris, France
16Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
17Radboud University Medical Centre, Nijmegen, Netherlands
18Division of Hematology, University Hospital of Santander, Basel, Switzerland
19Department of Hematology, Service d'Hématologie Centre Hospitalier de Lyon Sud, Lyon, France
20Department of Hematology, CHU Lapeyronie, Montpellier, France
21Hematology, INSERM UMR1098 - CHU Jean Minjoz, Besancon, France
22Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom
23Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
24St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
25Department for Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany
26Policlinico G.B. Rossi, Verona, Italy

Mari Morita, MD1*, Yoshimitsu Shimomura, MD2*, Hisako Hashimoto, MD, PhD3* and Takayuki Ishikawa, MD, PhD2

1Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan
2Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
3Department of Cell Therapy, Foundation for Biomedical Research and Innovation, Kobe, Japan

Namita Joshi, PhD, MS, BPharm1*, Linlin Luo, MSc1*, Xingyue Huang, PhD2*, Ghaith Mitri, MD2*, Belinda Lovelace, PharmD2*, An Pham, PharmD, MBA, FAHA2,3* and Xin Gao, PhD1*

1Pharmerit International, Bethesda, MD
2Mallinckrodt Pharmaceuticals, Hampton, NJ
3University of California San Francisco, San Francisco

Maddalena Noviello, PhD1*, Francesco Manfredi, MD1*, Tommaso Perini, MD1*, Oliveira Giacomo, PhD1*, Filippo Cortesi, PhD1*, Pantaleo De Simone, MD1*, Cristina Toffalori, PhD1*, Valentina Gambacorta, MSc1*, Attilio Bondanza, MD1, Raffaella Greco, MD1*, Jacopo Peccatori, MD1*, Giulia Casorati, PhD1*, Paolo Dellabona, MD, PhD1*, Nicoletta Cieri, MD, PhD2*, Luca Vago, MD, PhD1, Fabio Ciceri, MD1* and Chiara Bonini, MD1

1San Raffaele Hospital, Milan, Italy
2University of Milan, Milan, Italy

Elena V Morozova, MD, PhD1*, Ivan S Moiseev, MD, PhD1*, Maria V Barabanshikova, MD, PhD1*, Elena I Darskaya, MD, PhD1*, Sergey N. Bondarenko, PhD, MD1*, Ludmila S Zubarovskaya, MD, PhD, Professor1,2*, Vadim Baykov1*, Alexandr L Alyanski1*, Ildar M Barkhatov, MD, PhD1*, Axel R. Zander, MD, PhD, Professor1,3 and Boris V Afanasyev, MD, PhD, Professor1,2*

1R.M.Gorbacheva Memorial Institute of Oncology, Hematology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russian Federation
2Faculty of hematology, transfusiology and transplantology, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russian Federation
3Huntsman Cancer Institute, University of Utah, Salt Lake City

Nauman Saleem Siddiqui, MD1*, Mohammad Saud Khan, MD2*, Zubair Khan, MD2*, Hermann Simo, MD2*, Jamal Mohamad Saleh, MD2* and Kellie Sprague, MD1

1Tufts Medical Center, Boston, MA
2University of Toledo Medical Center, Toledo, OH

Monzr M. Al Malki, MD1, Sanjeet Dadwal, MD2*, Dongyun Yang, PhD3*, Sally Mokhtari, PhD.4*, Thai Cao, MD1*, Ketevan Gendzekhadze, PhD5*, Ibrahim Aldoss, MD1, Pablo Parker, MD1*, Margaret R. O'Donnell, MD1, David S. Snyder, MD1, David Senitzer, PhD5, Joseph Rosenthal, MD, MS6, Auayporn P. Nademanee, MD, BS1, Don Diamond, PhD7*, John Zaia, MD8*, Stephen J. Forman, MD, FACP1 and Ryotaro Nakamura, MD1

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Department of Infectious Disease, City of Hope National Medical Center, Duarte, CA
3Department of Information Sciences-BRI, City of Hope National Medical Center, Duarte, CA
4Department of Clinical Translational Program Development, City of Hope National Medical Center, Duarte, CA
5Histocompatibility Lab, City of Hope National Medical Center, Duarte, CA
6Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
7Experimental Therapeutics-BRI, City of Hope National Medical Center, Duarte, CA
8Center for Gene Therapy - BRI, City of Hope National Medical Center, Duarte, CA

Ya Gao, MD1*, Baohong Ping2*, Ying Xu3*, Chunyan Yang3*, Weibin Zhuo3* and Qifa Liu, MD1

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Huiqiao, Nanfang Hospital, Southern Medical University, guangzhou, China
3Nanfang Hospital, Southern Medical University, guangzhou, China

George Chen, MD1, Yali Zhang, MS1*, Joseph Dennis Tario, PhD2*, Amanda Herko Przespolewski, MD1, Dalin Pan2*, Patrick Mellors, MD1*, Christine Ho, MD1*, Sophia R. Balderman, MD1, Maureen Ross, MD, PhD1, Liselotte Brix, PhD3*, Paul K. Wallace, MS, PhD2, Philip L. McCarthy, MD1 and Theresa Hahn, PhD1

1Medicine, Roswell Park Cancer Institute, Buffalo, NY
2Flow Cytometry, Roswell Park Cancer Institute, Buffalo, NY
3Immudex, Copenhagen, Denmark

Giuseppe Milone, MD, PhD1, Viviana Frontini2*, Alessandra Cupri2*, Salvatore Leotta2*, Annalia DiMarco2*, Carla Consoli2*, Luca Scalise2*, Giuseppe Sapienza2*, Gaetano Moschetti3*, Giuseppe Avola2*, Andrea Spadaro2* and AnnaElisa Marchese, PhD2*

1Azienda Ospedaliera Policlinico-Vittorio Emanuele, Catania, Italy
2Azienda Policlinico Vittorio Emanuele, Catania, Italy
3GruppoSamed, Catania, Italy

Richard Thomas Maziarz, MD1, John Edwards, MD2*, James Essell, MD3, Cesar Freytes, MD4, Chatchada Karanes, MD5*, Ayman Saad, MD6, Dimitrios Tzachanis, MD, PhD7, Monica Diaz8*, Amanda Medcalf8*, Daniel Fremgen8*, Chris Storgard, MD8* and Abhinav Deol, MD9

1Oregon Health & Science University, Portland, OR
2Indiana Blood and Marrow Transplantation, Indianapolis, IN
3Jewish Hospital Mercy Health, Ohio
4Texas Transplant Physician Group, San Antonio, TX
5Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
6University of Alabama At Birmingham, Birmingham, AL
7University of California, San Diego, San Diego, CA
8Fate Therapeutics, Inc., San Diego, CA
9Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI

Maria Teresa Lupo Stanghellini, MD1*, Francesca Lorentino, MD1*, Gabriele Antonarelli2*, Elisa Sala, MD1*, Raffaella Greco, MD1*, Mara Morelli, MD1*, Magda Marcatti, MD1*, Simona Piemontese, MD1*, Andrea Assanelli, MD1*, Matteo Giovanni Carrabba, MD1*, Fabio Serpenti2*, Fabio Giglio, MD1*, Sara Mastaglio, MD3*, Sarah Marktel, MD1*, Francesca Lunghi, MD1*, Elena Guggiari, MD1*, Francesca Pavesi, MD1*, Luca Vago, MD, PhD1, Consuelo Corti, MD1*, Massimo Bernardi, MD1*, Jacopo Peccatori, MD1* and Fabio Ciceri, MD1,2*

1Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute IRCCS, Milano, Italy
2Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milano, Italy
3Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute IRCCS, Milano, Milano, Italy

Mehrdad Hefazi, MD1, Kimberly J. Langer, D.N.P., C.N.P.1*, Alli Louise McClanahan, CNP1*, Jeffrey L. Winters, MD2, Dennis A. Gastineau, MD2, Eapen K. Jacob, MD3, Justin D. Kreuter2*, Manish Gandhi, MD4*, William J. Hogan, MBBCh1, Mark R. Litzow, MD1, Shahrukh K. Hashmi, MD, MPH1, Vivek N Iyer, MD5*, Rodrigo Cartin-Ceba, MD6* and Mrinal M. Patnaik, MD, MBBS1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Transfusion Medicine, Mayo Clinic, Rochester, MN
3Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4Division of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
6Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Scottsdale, AZ

Emily Blyth1,2,3*, Helen Mcguire4*, Simone Rizzetto5*, Barbara Withers6*, Leighton Clancy, BSc PhD3*, Fabio Luciani7* and David Gottlieb, MBBS, MD, FRACP, FRCPA8,9,10*

1Westmad Hospital, Blood and Marrow Transplant Unit, Sydney, Australia
2Westmead Hospital, University of Sydney, Westmead Institute of Medical Research, Westmead, AUS
3Westmead Hospital, Sydney Cellular Therapies Laboratory, Sydney, Australia
4University of Sydney, Centenary Institute, Sydney, Australia
5University of New South Wales, Sydney, Australia
6Westmead Hospital, University of Sydney, Westmead Insitutue of Medical Research, Sydney, Australia
7Kirby Institute, University of New South Wales, Sydney, Australia
8University of Sydney, Sydney, Australia
9Westmead Hospital, University of Sydney, Sydney, Australia
10Westmead Hospital, Sydney, AUS

Takahiko Miyama, MD1*, Takakazu Kawase, MD, PhD1*, Yasuko Honjo, PhD1*, Kazutaka Kitaura, DVM, PhD2*, Tadasu Shin-I, PhD3*, Ryuji Suzuki, DVM, PhD2,4* and Tatsuo Ichinohe, MD, PhD1

1Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
2Repertoire Genesis Incorporation, Ibaraki, Japan
3BITS Incorporation, Tokyo, Japan
4Department of Rheumatology and Clinical Immunology, Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan

Betty K. Hamilton, MD1, Lisa Rybicki, MS2*, David Grove, PhD3*, Christina Ferraro, CNP4*, Jamie Starn4*, Brittany Hodgeman4*, Jamie Elberson4*, Victoria Winslow4*, Joshua Workman5*, Donna M. Abounader6*, Aaron T. Gerds, MD, MS7, Rabi Hanna, MD6*, Matt Kalaycio, MD1, Ronald Sobecks, M.D.4*, Navneet S. Majhail, MD, MS4 and Raed Dweik, M.D.8*

1Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH
2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
3Lerner Research Institute, Pathobiology, Cleveland Clinic, Cleveland, OH
4Taussig Cancer Institute, Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH
5Taussig Cancer Institute, Blood and Marrow Transplant Program, Cleveland Clinic, Clevealnd, OH
6Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH
8Lerner Research Institute, Pulmonary Medicine, Cleveland Clinic, Cleveland, OH

Mauricette Michallet, MD, PhD1, Mohamad Sobh1*, Alexandre Deloire, CRA1*, Daniela Revesz, MD2*, Youcef Chelgoum, MD2*, Mohamed El-Hamri, CRA1*, Fiorenza Barraco, MD1*, Helene Labussiere-Wallet, MD1*, Franck Emmanuel Nicolini, MD, PhD1 and Olivier Hequet, MD2*

1Hematology department 1 G, Centre Hospitalier Lyon Sud, Pierre Benite, France
2Etablissement Francais du Sang, Lyon, France

Monica M Rivera Franco, M.D.1, Eucario Leon Rodriguez, M.D.2*, Diana Gomez Martin, M.D.3*, Jorge Romo Tena, M.D.3*, Guillermo Juarez Vega, Ph.D.4*, Javier Merayo Chalico, M.D.5* and Jorge Alcocer Varela, M.D.3*

1Hematology and Oncology, Instituto Nacional De Ciencias Medicas Y Nutricion Salvador Zubiran, Ciudad De Mexico, MEX
2Hematology and Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
3Rheumatology and Immunology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
4Flow Cytometry Unit. Red de Apoyo a la Investigación CIC-UNAM, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
5Rheumatology and Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico

Robert Korngold, PhD1, Kira Goldgirsh, MS2*, Themba Nyirenda, Ph.D.3*, Phyllis McKiernan, APN, MSN4*, Ryan Emerson, PhD5*, Marissa Vignali, PhD6*, Julie Rubinstein6*, Harlan Robins, PhD7*, David Siegel, MD, PhD8 and Michele L. Donato, MD2

1John Theurer Cancer Center, Hackensack Univ. Med. Ctr. Jurist Research Bldg., Hackensack, NJ
2John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
3Department of Biomedical Research, Hackensack University Medical Center, Hackensack, NJ
4John Theurer Cancer Center, Hackensack University Medical Center, Paramus, NJ
5Adaptive Biotechnologies Corp., Seattle, WA
6Adaptive Biotechnologies, Seattle, WA
7Fred Hutchinson Cancer Research Center, Seattle, WA
8John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ

Mojtaba Akhtari, MD1 and Mindy Hsiao, MD2*

1Norris Cancer Center, USC, Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Los Angeles, CA
2LAC-USC Internal Medicine Residency, Los Angeles, CA

Katsuyuki Nishi, MD1*, Junya Kanda, MD, PhD2, Masakatsu Hishizawa, MD, PhD3*, Toshiyuki Kitano, MD1*, Tadakazu Kondo, MD, PhD1, Kouhei Yamashita, MD, PhD1 and Akifumi Takaori-Kondo, MD, PhD4

1Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, JPN
2Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, JPN
4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

*signifies non-member of ASH